{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibvhtg5ak744v6qbuwqk3rcnl2j5q6vri2h6e6rh2do3fwvxbn33a",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhr55aujujh2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihgy3w4tkopn4k74vml6dlbuso3tv3fp5vtkbpwubq4sxpmhbcxhi"
    },
    "mimeType": "image/jpeg",
    "size": 312705
  },
  "path": "/news/2026-03-dual-immune-response-hiv-medication.html",
  "publishedAt": "2026-03-23T17:30:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on the board. This is how the body might control HIV on its own: The virus would be contained and unable to replicate or spread, but it would not have been eliminated. This is the goal of Professor Ole Schmeltz Søgaard and an international team of researchers—to enable more patients' immune systems to keep the virus permanently in check without the need for daily medication. Their findings suggest that this requires two key components working in tandem: antibodies and T cells.",
  "title": "Dual immune response may keep HIV in check without medication"
}